73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Transforming cancer diagnosis and treatment with cerium/lanthanum-134

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari
Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N
Map of tumors' immune cell populations points to new targets for immunotherapy

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno
Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th
New genetic study reveals why some women get aggressive breast and ovarian cancer

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an

New genetic study reveals why some women get aggressive breast and ovarian cancer

byUniversity of BergenIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) an
Study identifies new potential treatment option for triple negative breast cancer

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro
ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin
Study weighs risks and benefits of phase I trials in pediatric cancer

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate
Forty-three percent of melanoma patients have chronic complications from immunotherapies

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among
Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new

Increasing the dose intensity of chemotherapy reduces the risk of breast cancer recurrence and death

by Medical Research CouncilCredit: PixabayGiving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new
Breast MRI effective at detecting cancer in dense breasts, finds study

Breast MRI effective at detecting cancer in dense breasts, finds study

byRadiological Society of North AmericaForest plots show the incremental cancer detection rate (CDR) per 1000 screenings per modality. (A) Studies with handheld US. (B) Studies with automated wh

Breast MRI effective at detecting cancer in dense breasts, finds study

byRadiological Society of North AmericaForest plots show the incremental cancer detection rate (CDR) per 1000 screenings per modality. (A) Studies with handheld US. (B) Studies with automated wh
New drug combination shows promise for small cell lung cancer

New drug combination shows promise for small cell lung cancer

byThe Mount Sinai HospitalATR expression and the antitumor effect of ATRi in SCLC. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado4618Researchers at the Icahn School of Medici

New drug combination shows promise for small cell lung cancer

byThe Mount Sinai HospitalATR expression and the antitumor effect of ATRi in SCLC. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado4618Researchers at the Icahn School of Medici